Literature DB >> 15788779

Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha.

David Stellwagen1, Eric C Beattie, Jae Y Seo, Robert C Malenka.   

Abstract

The proinflammatory cytokine tumor necrosis factor-alpha (TNFalpha) causes a rapid exocytosis of AMPA receptors in hippocampal pyramidal cells and is constitutively required for the maintenance of normal surface expression of AMPA receptors. Here we demonstrate that TNFalpha acts on neuronal TNFR1 receptors to preferentially exocytose glutamate receptor 2-lacking AMPA receptors through a phosphatidylinositol 3 kinase-dependent process. This increases excitatory synaptic strength while changing the molecular stoichiometry of synaptic AMPA receptors. Conversely, TNFalpha causes an endocytosis of GABA(A) receptors, resulting in fewer surface GABA(A) receptors and a decrease in inhibitory synaptic strength. These results suggest that TNFalpha can regulate neuronal circuit homeostasis in a manner that may exacerbate excitotoxic damage resulting from neuronal insults.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15788779      PMCID: PMC6725093          DOI: 10.1523/JNEUROSCI.4486-04.2005

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  63 in total

Review 1.  The role of TNFalpha and lymphotoxin in demyelinating disease.

Authors:  C Lock; J Oksenberg; L Steinman
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  The glutamate receptor ion channels.

Authors:  R Dingledine; K Borges; D Bowie; S F Traynelis
Journal:  Pharmacol Rev       Date:  1999-03       Impact factor: 25.468

3.  Role of AMPA receptor cycling in synaptic transmission and plasticity.

Authors:  C Lüscher; H Xia; E C Beattie; R C Carroll; M von Zastrow; R C Malenka; R A Nicoll
Journal:  Neuron       Date:  1999-11       Impact factor: 17.173

Review 4.  HIV-1-induced neuronal injury in the developing brain.

Authors:  L G Epstein; H A Gelbard
Journal:  J Leukoc Biol       Date:  1999-04       Impact factor: 4.962

5.  Knockdown of AMPA receptor GluR2 expression causes delayed neurodegeneration and increases damage by sublethal ischemia in hippocampal CA1 and CA3 neurons.

Authors:  K Oguro; N Oguro; T Kojima; S Y Grooms; A Calderone; X Zheng; M V Bennett; R S Zukin
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

6.  Neurological dysfunctions in mice expressing different levels of the Q/R site-unedited AMPAR subunit GluR-B.

Authors:  D Feldmeyer; K Kask; R Brusa; H C Kornau; R Kolhekar; A Rozov; N Burnashev; V Jensen; O Hvalby; R Sprengel; P H Seeburg
Journal:  Nat Neurosci       Date:  1999-01       Impact factor: 24.884

7.  Use-dependent AMPA receptor block in mice lacking GluR2 suggests postsynaptic site for LTP expression.

Authors:  Z F Mainen; Z Jia; J Roder; R Malinow
Journal:  Nat Neurosci       Date:  1998-11       Impact factor: 24.884

8.  Alterations in AMPA receptor subunit expression after experimental spinal cord contusion injury.

Authors:  S D Grossman; B B Wolfe; R P Yasuda; J R Wrathall
Journal:  J Neurosci       Date:  1999-07-15       Impact factor: 6.167

9.  Status epilepticus decreases glutamate receptor 2 mRNA and protein expression in hippocampal pyramidal cells before neuronal death.

Authors:  S Y Grooms; T Opitz; M V Bennett; R S Zukin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

Review 10.  TNF-induced signaling in apoptosis.

Authors:  P C Rath; B B Aggarwal
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.542

View more
  356 in total

1.  Is the Gly82Ser polymorphism in the RAGE gene relevant to schizophrenia and the personality trait psychoticism?

Authors:  Petra Suchankova; Jonas Klang; Carin Cavanna; Göran Holm; Staffan Nilsson; Erik G Jönsson; Agneta Ekman
Journal:  J Psychiatry Neurosci       Date:  2012-02       Impact factor: 6.186

Review 2.  Cytokines and brain excitability.

Authors:  Michael A Galic; Kiarash Riazi; Quentin J Pittman
Journal:  Front Neuroendocrinol       Date:  2011-12-27       Impact factor: 8.606

Review 3.  Homeostatic synaptic plasticity: local and global mechanisms for stabilizing neuronal function.

Authors:  Gina Turrigiano
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-01-01       Impact factor: 10.005

4.  A swell in the armamentarium of antiepileptic drug targets.

Authors:  Karthik Rajasekaran; Howard Parker Goodkin
Journal:  Epilepsy Curr       Date:  2011-11       Impact factor: 7.500

Review 5.  Exocytosis in astrocytes: transmitter release and membrane signal regulation.

Authors:  Alenka Guček; Nina Vardjan; Robert Zorec
Journal:  Neurochem Res       Date:  2012-04-21       Impact factor: 3.996

Review 6.  The role of inflammation in epilepsy.

Authors:  Annamaria Vezzani; Jacqueline French; Tamas Bartfai; Tallie Z Baram
Journal:  Nat Rev Neurol       Date:  2010-12-07       Impact factor: 42.937

7.  A p38 mitogen-activated protein kinase-dependent mechanism of disinhibition in spinal synaptic transmission induced by tumor necrosis factor-alpha.

Authors:  Haijun Zhang; Hui Nei; Patrick M Dougherty
Journal:  J Neurosci       Date:  2010-09-22       Impact factor: 6.167

8.  Effect of chronic delivery of the Toll-like receptor 4 antagonist (+)-naltrexone on incubation of heroin craving.

Authors:  Florence R Theberge; Xuan Li; Sarita Kambhampati; Charles L Pickens; Robyn St Laurent; Jennifer M Bossert; Michael H Baumann; Mark R Hutchinson; Kenner C Rice; Linda R Watkins; Yavin Shaham
Journal:  Biol Psychiatry       Date:  2013-02-04       Impact factor: 13.382

Review 9.  Stem Cell-Based Immunomodulation After Stroke: Effects on Brain Repair Processes.

Authors:  Marieke C S Boshuizen; Gary K Steinberg
Journal:  Stroke       Date:  2018-05-03       Impact factor: 7.914

10.  Tumor necrosis factor (TNF) modulates synaptic plasticity in a concentration-dependent manner through intracellular calcium stores.

Authors:  Nicola Maggio; Andreas Vlachos
Journal:  J Mol Med (Berl)       Date:  2018-08-02       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.